Provided by Tiger Trade Technology Pte. Ltd.

Argenx SE

1,031.66
+8.450.83%
Post-market: 1,031.660.00000.00%19:56 EDT
Volume:227.99K
Turnover:233.74M
Market Cap:64.52B
PE:39.36
High:1,039.36
Open:1,010.78
Low:1,005.78
Close:1,023.21
52wk High:1,061.57
52wk Low:661.85
Shares:62.54M
Float Shares:62.45M
Volume Ratio:0.86
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):26.21
EPS(LYR):19.57
ROE:23.63%
ROA:11.63%
PB:7.67
PE(LYR):52.72

Loading ...

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Aug 03

European Equities Traded in the US as American Depositary Receipts Track Sharply Higher in Thursday Trading

MT Newswires Live
·
Jul 30

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT) and Argenx Se (ARGX)

TIPRANKS
·
Jul 29

Argenx is Maintained at Outperform by Wedbush

Dow Jones
·
Jul 28

Argenx price target raised to $1,050 from $1,000 at Wedbush

TIPRANKS
·
Jul 28

Argenx Se : Wedbush Raises Target Price to $1050 from $1000

THOMSON REUTERS
·
Jul 28

Forte Biosciences downgraded to Equal Weight from Overweight at Barclays

TIPRANKS
·
Jul 28

Argenx's Forte Bio Deal Validates CEO Change

Dow Jones
·
Jul 28

Movement Alert|Argenx SE Falls 3.01% in Regular Trading, $2.2 Billion Cash Acquisition of Forte Biosciences Triggers Market Digestion

Market Focus
·
Jul 28

Analysts Are Bullish on These Healthcare Stocks: Demant (WILLF), Argenx Se (ARGX)

TIPRANKS
·
Jul 28

After Forte acquisition, H.C. Wainwright says First Tracks could be target

TIPRANKS
·
Jul 28

Midday Fly By: Argenx to buy Forte, Nvidia in talks for $250B OpenAI backstop

TIPRANKS
·
Jul 27

Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Omeros (OMER)

TIPRANKS
·
Jul 27

European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading

MT Newswires Live
·
Jul 27

Wedbush Raises Price Target on Argenx to $1,050 From $1,000, Maintains Outperform Rating

MT Newswires Live
·
Jul 27

Argenx is Maintained at Neutral by Baird

Dow Jones
·
Jul 27

Argenx price target raised to $932 from $867 at Baird

TIPRANKS
·
Jul 27

Argenx's Vyvgart Beat Impressive With Focus On Upcoming Myositis Data, RBC says

MT Newswires Live
·
Jul 25

Argenx is Maintained at Market Outperform by Citizens

Dow Jones
·
Jul 24

RBC Raises Price Target on argenx to $1,025 From $945, Keeps Outperform Rating

MT Newswires Live
·
Jul 24